Qiming Venture Partners is a prominent venture capital firm established in 2006 and headquartered in Shanghai, with additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early to growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology in China. Since its inception, Qiming has built a reputation as a leading investment firm in the region, managing multiple funds with over $1 billion in assets. The firm aims to support promising entrepreneurs and innovative businesses, contributing to the development of China's dynamic economic landscape.
Houmo.AI is a semiconductor company that develops an integrated circuit storage technology for AI computing. The company aims to use disruptive technologies to create AI chips with a "ten-fold effect", to meet the huge computing power demand in the era of true artificial intelligence, and to use unlimited computing power to change the world. Houmo.AI was founded by Dr. Wu Qiang in 2020.
Clique is building identity oracles that connect web2 user behavior data with web3 applications. We leverage advanced cryptographic tech like ZKP, TEE, and MPC to develop modular solutions with customizable privacy assumptions. Our main products are designed to help protocols, creators, and brands identify high-value users/fans, perform Sybil-resistant checks and distribute incentives accordingly. We already have 100+ partners across major L1/L2s, exchanges, marketplaces, NFT/GameFi/SocialFi projects, etc. We were previously incubated by Alliance DAO and Stanford Blockchain Accelerator and raised millions in funding from renowned VCs like GGV, Qiming, Infinity Ventures Crypto, Sky9, SevenX, Smrti Lab, etc. Our team has a strong technical background and comes from prestigious institutions like Duke, Cambridge, NUS, Tsinghua, Citi bank, Brevan Howard, etc. Our advisors include top cryptography researchers, past founders of established media companies, as well as famous Hollywood directors and writers.
ACXEL Tech develops large area electronics have given us flat panel displays and flexible, wearable devices. ACXEL takes these ‘active’ pixels and puts them to work transporting liquid droplets – precisely and at amazing speed. Millions of pixels are transformed into tiny engines moving samples around via a high throughput, low cost and programmable platform, offering a wide range of possibilities in chemistry, biology and medtech.
Xinchuangyuan Semiconductor
Series A in 2021
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment. Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.
Houmo.AI is a semiconductor company that develops an integrated circuit storage technology for AI computing. The company aims to use disruptive technologies to create AI chips with a "ten-fold effect", to meet the huge computing power demand in the era of true artificial intelligence, and to use unlimited computing power to change the world. Houmo.AI was founded by Dr. Wu Qiang in 2020.
Matrixport is your gateway to digital economy where you can trade, custody, invest and borrow crypto assets all in one stop. With rich industry resources and leading technology capabilities, Matrixport aims to create the next generation digital financial service platform. Their vision is to enable a more open and equal financial system using blockchain technologies. Matrixport has launched trading, digital asset custody, and cryptocurrency lending service for clients around the world, with even more innovative product offerings to come. Matrixport is headquartered in Singapore with offices worldwide.
imToken Pte. Ltd. is a Singapore-based company that specializes in developing a blockchain-based cryptocurrency wallet and digital asset management tools. Founded in 2016, imToken enables users to manage multi-chain assets and facilitates secure token exchanges within its wallet. The platform features a DApp browser that supports decentralized token-to-token transactions, enhancing the user experience in the blockchain ecosystem. Over the years, imToken has garnered a global user base, becoming one of the largest Ethereum wallets in the world. The company operates as a subsidiary of Hangzhou Rongshi Technology Co., Ltd. and is dedicated to making blockchain technology accessible and user-friendly for a broader audience.
Bouffalo Lab designs and develops semiconductor chips. The company offers integrated Wi-Fi chipsets for low-power and high-performance application development and other products. Its products are used in smart homes, cities, manufacturing, robots, and wearable systems, as well as communication equipment and in-vehicle intelligent systems. The company is based in Shanghai, China.
HashQuark is a blockchain infrastructure services provider specializing in staking solutions for Proof of Stake (PoS) and Delegated Proof of Stake (DPoS) ecosystems. Founded in 2018 and based in Grand Cayman, the company offers a range of services, including staking for institutions, individuals, and market professionals, as well as advanced staking cloud solutions that facilitate efficient node operations. HashQuark has established a global server deployment supporting all major PoS blockchains, ensuring a secure and stable platform for token holders. Through its Staking Cloud, the company enables users to store their tokens and earn staking rewards, making it an attractive option for both individual and institutional investors seeking reliable investment opportunities in the blockchain space.
Bouffalo Lab designs and develops semiconductor chips. The company offers integrated Wi-Fi chipsets for low-power and high-performance application development and other products. Its products are used in smart homes, cities, manufacturing, robots, and wearable systems, as well as communication equipment and in-vehicle intelligent systems. The company is based in Shanghai, China.
APT Medical Inc. specializes in the research, development, manufacture, and sale of invasive interventional medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products such as diagnostic and treatment tools and intervention accessories. Additionally, APT Medical provides OEM and ODM services for catheter and metal products. Established in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, positioning itself as a key player in the minimally invasive medical devices sector.
ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China.
The Life Technology Business Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology.
The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005.
ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.
APT Medical Inc. specializes in the research, development, manufacture, and sale of invasive interventional medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products such as diagnostic and treatment tools and intervention accessories. Additionally, APT Medical provides OEM and ODM services for catheter and metal products. Established in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, positioning itself as a key player in the minimally invasive medical devices sector.
Akulaku Inc. is a consumer finance platform based in Jakarta, Indonesia, established in 2016. The company specializes in offering online financial credit services to customers across Southeast Asia. Its services include shopping in installments through an independently managed online marketplace and various other platforms, as well as providing flexible cash loans. Akulaku's mission is to enhance the quality of life for both partners and consumers by creating a comprehensive and reliable financial ecosystem.
APT Medical Inc. specializes in the research, development, manufacture, and sale of invasive interventional medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products such as diagnostic and treatment tools and intervention accessories. Additionally, APT Medical provides OEM and ODM services for catheter and metal products. Established in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, positioning itself as a key player in the minimally invasive medical devices sector.
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.
Bouffalo Lab designs and develops semiconductor chips. The company offers integrated Wi-Fi chipsets for low-power and high-performance application development and other products. Its products are used in smart homes, cities, manufacturing, robots, and wearable systems, as well as communication equipment and in-vehicle intelligent systems. The company is based in Shanghai, China.
ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China.
The Life Technology Business Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology.
The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005.
ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.
Akulaku Inc. is a consumer finance platform based in Jakarta, Indonesia, established in 2016. The company specializes in offering online financial credit services to customers across Southeast Asia. Its services include shopping in installments through an independently managed online marketplace and various other platforms, as well as providing flexible cash loans. Akulaku's mission is to enhance the quality of life for both partners and consumers by creating a comprehensive and reliable financial ecosystem.
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.
APT Medical Inc. specializes in the research, development, manufacture, and sale of invasive interventional medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products such as diagnostic and treatment tools and intervention accessories. Additionally, APT Medical provides OEM and ODM services for catheter and metal products. Established in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, positioning itself as a key player in the minimally invasive medical devices sector.
Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.
ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China.
The Life Technology Business Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology.
The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005.
ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.
Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.
ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China.
The Life Technology Business Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology.
The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005.
ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.
Intelligent Automation was founded in 2006 in Zhuhai. In 2015 they became the famous list firm CYG’s subsidiary and stock code is 600525.SH. They have been focusing on the research and development of high-end automatic test equipment and assembly equipment. Hitherto they have provided their high quality solution on the industries of consumer electronic, automotive, medical, new energy and LED lighting, industry.
APT Medical Inc. specializes in the research, development, manufacture, and sale of invasive interventional medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products such as diagnostic and treatment tools and intervention accessories. Additionally, APT Medical provides OEM and ODM services for catheter and metal products. Established in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, positioning itself as a key player in the minimally invasive medical devices sector.
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.
Intelligent Automation was founded in 2006 in Zhuhai. In 2015 they became the famous list firm CYG’s subsidiary and stock code is 600525.SH. They have been focusing on the research and development of high-end automatic test equipment and assembly equipment. Hitherto they have provided their high quality solution on the industries of consumer electronic, automotive, medical, new energy and LED lighting, industry.
Aeonmed Medical Treatment (至尊租车) is a manufacturer and supplier of operating theatre and ICU devices, and medical treatment system solutions. Since its foundation, Aeonmed has always been guided by the clinical demands, and dedicated to the study of clinical medical equipment and solutions. Now, Aeonmed business covers three major product portfolios, including anesthesia and operation support, emergency and critical care and medical engineering equipment, and five major medical system solutions including laminar flow monitoring, environment and equipment configuration, centralized gas supply, process quality control and information integration. Currently, Aeon has more than 600 authorized and declared patents, among which there are more than 400 patents for invention, maintaining an increase of over 100 patents each year.
Shanghai Fangtek Electronics Co., Ltd. designs, develops, and markets analog and mixed-signal power management integrated circuits for communication, computing, and consumer markets. Its products include audio power amplifiers, LED drivers, SIM card controllers, analog switches, reset integrated circuits, charger protection products, and voltage regulators. The company serves audio, lighting, and supply voltage regulation applications; and mobile phone, MP3/4, GPS, mini sound box, and MID applications. Shanghai Fangtek Electronics Co., Ltd. was founded in 2003 and is based in Shanghai, China with an additional office in Shenzhen, China.